Feed / UTHR

United Therapeutics Corporation

UTHR

Healthcare · 513.37 -1.4% today

Participation confirmed · construction unavailableMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

United Therapeutics Corporation's move is being confirmed by its market group.

The latest filing evidence is available. 14 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.

What changed
  • Revenue decreased 1.9% versus the comparable filing period.
Company-1.4% todayVolume comparison unavailable
Market group14 of 18 activeBiotech Rare Diseases · active
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 12 of 18 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ROIV begins moving with the group.

Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.

Watch this read

Who this business touches

The relationships behind UTHR

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

CORCencora, Inc.distributorFeb 25, 2026 ▾

“We distribute Unituxin in the United States through an exclusive distribution agreement with Cencora Global Procurement Ltd ( Cencora ).”

ICUIICU Medical, Inc.supplierFeb 25, 2026 ▾

“Historically, Smiths Medical, Inc.”

Depended on by

LQDALiquidia CorporationcompetitorMay 11, 2026 ▾

“Our Treprostinil Injection product to treat PAH faces competition primarily from the continued use of the branded Remodulin sold by United Therapeutics as well as additional generic treprostinil products offered by Teva, Par Pharmaceutical, Dr.”

Filing peers

LQDA

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

UTHR is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.